Debt-to-equity of TENAX THERAPEUTICS, INC. from 31 Jan 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TENAX THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 31 Jan 2012 to 30 Sep 2025.
  • TENAX THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 4.1%, a 47% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

TENAX THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 4.1% -3.7% -47% 30 Sep 2025
Q2 2025 3.1% -16% -84% 30 Jun 2025
Q1 2025 3.8% -12% -76% 31 Mar 2025
Q4 2024 5.2% -7.6% -59% 31 Dec 2024
Q3 2024 7.8% -2.9% -27% 30 Sep 2024
Q2 2024 20% +5.9% +43% 30 Jun 2024
Q1 2024 16% -4.2% -21% 31 Mar 2024
Q4 2023 13% -33% -72% 31 Dec 2023
Q3 2023 11% -27% -71% 30 Sep 2023
Q2 2023 14% -22% -62% 30 Jun 2023
Q1 2023 20% -28% -59% 31 Mar 2023
Q4 2022 46% +7% +18% 31 Dec 2022
Q3 2022 38% -3.8% -9.1% 30 Sep 2022
Q2 2022 36% -4.6% -11% 30 Jun 2022
Q1 2022 48% +5.8% +14% 31 Mar 2022
Q4 2021 39% -7.8% -17% 31 Dec 2021
Q3 2021 41% -10% -19% 30 Sep 2021
Q2 2021 40% -11% -22% 30 Jun 2021
Q1 2021 42% +8.8% +27% 31 Mar 2021
Q4 2020 47% +27% +130% 31 Dec 2020
Q3 2020 51% +38% +285% 30 Sep 2020
Q2 2020 52% +40% +336% 30 Jun 2020
Q1 2020 33% +21% +176% 31 Mar 2020
Q4 2019 20% +10% +99% 31 Dec 2019
Q3 2019 13% +3.9% +42% 30 Sep 2019
Q2 2019 12% +3% +34% 30 Jun 2019
Q1 2019 12% +0.67% +5.9% 31 Mar 2019
Q4 2018 10% -10% -50% 31 Dec 2018
Q3 2018 9.4% -18% -65% 30 Sep 2018
Q2 2018 8.9% -21% -70% 30 Jun 2018
Q1 2018 11% -18% -61% 31 Mar 2018
Q4 2017 20% -7% -26% 31 Dec 2017
Q3 2017 27% +2.2% +8.9% 30 Sep 2017
Q2 2017 30% +7.3% +33% 30 Jun 2017
Q1 2017 29% +9.1% +45% 31 Mar 2017
Q4 2016 27% +9.2% +51% 31 Dec 2016
Q3 2016 25% +8.2% +50% 30 Sep 2016
Q2 2016 22% +6.5% +41% 30 Jun 2016
Q1 2016 20% +5.4% +36% 31 Mar 2016
Q4 2015 18% +4.7% +35% 31 Dec 2015
Q3 2015 17% +3.5% +27% 31 Oct 2015
Q2 2015 16% +2.9% +23% 31 Jul 2015
Q1 2015 15% -2.8% -16% 30 Apr 2015
Q4 2014 14% -32% -70% 31 Jan 2015
Q3 2014 13% -2614% -100% 31 Oct 2014
Q2 2014 13% +792% 31 Jul 2014
Q1 2014 17% +483% 30 Apr 2014
Q4 2013 46% +746% 31 Jan 2014
Q3 2013 2627% +3704% 31 Oct 2013
Q2 2013 -779% -326% -72% 31 Jul 2013
Q1 2013 -466% -49% -12% 30 Apr 2013
Q4 2012 -700% -403% -136% 31 Jan 2013
Q3 2012 -1077% 31 Oct 2012
Q2 2012 -453% 31 Jul 2012
Q1 2012 -416% 30 Apr 2012
Q4 2011 -297% 31 Jan 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.